Short- And long-term outcomes of acute severe ulcerative colitis in Korea: The 1999-2005 cohort

Inflammatory Bowel Diseases

Volumn 21, Issue 8, 2015, Pages 1825-1831

  Lee, Ho Su ^a   Yang, Suk Kyun ^a   Soh, Jae Seung ^a   Lee, Seohyun ^a   Bae, Jung Ho ^a   Lee, Hyo Jeong ^a   Park, Sang Hyoung ^a   Yang, Dong Hoon ^a   Kim, Kyung Jo ^a   Ye, Byong Duk ^a   Byeon, Jeong Sik ^a   Myung, Seung Jae ^a   Yoon, Yong Sik ^a   Yu, Chang Sik ^a   Kim, Jin Ho ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Acute severe ulcerative colitis; Colectomy; Korea; Outcome; Treatment

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; HEPARIN; HYDROCORTISONE; MERCAPTOPURINE; METHYLPREDNISOLONE; TUMOR NECROSIS FACTOR INHIBITOR; IMMUNOSUPPRESSIVE AGENT; STEROID;

ACUTE SEVERE ULCERATIVE COLITIS; ADOLESCENT; ADULT; AGED; ARTICLE; COLON RESECTION; FEMALE; HOSPITAL READMISSION; HUMAN; INDEX HOSPITALIZATION; KOREA; LOWER EXTREMITY DEEP VEIN THROMBOSIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STEROID THERAPY; TREATMENT RESPONSE; ULCERATIVE COLITIS; ACUTE DISEASE; COLITIS, ULCERATIVE; COMPARATIVE STUDY; FOLLOW UP; HOSPITALIZATION; MIDDLE AGED; PROGNOSIS; REMISSION; SEVERITY OF ILLNESS INDEX; SOUTH KOREA; STATISTICS AND NUMERICAL DATA; TIME FACTOR; YOUNG ADULT;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; COLECTOMY; COLITIS, ULCERATIVE; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PROGNOSIS; REMISSION INDUCTION; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STEROIDS; TIME FACTORS; YOUNG ADULT;

EID: 84946924102     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0000000000000447     Document Type: Article

References (39)

1. Frolkis AD, Dykeman J, Negron ME, et al. Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies. Gastroenterology. 2013;145:996-1006.
2. Hiwatashi N, Yao T, Watanabe H, et al. Long-term follow-up study of ulcerative colitis in Japan. J Gastroenterol. 1995;30(suppl 8):13-16.
3. Jiang L, Xia B, Li J, et al. Retrospective survey of 452 patients with inflammatory bowel disease in Wuhan city, central China. Inflamm Bowel Dis. 2006;12:212-217.
4. Park SH, Kim YM, Yang SK, et al. Clinical features and natural history of ulcerative colitis in Korea. Inflamm Bowel Dis. 2007;13:278-283.
5. Wang Y, Ouyang Q; APDW 2004 Chinese IBD Working Group. Ulcerative colitis in China: retrospective analysis of 3100 hospitalized patients. J Gastroenterol Hepatol. 2007;22:1450-1455.
6. Chow DK, Leong RW, Tsoi KK, et al. Long-term follow-up of ulcerative colitis in the Chinese population. Am J Gastroenterol. 2009;104:647-654.
7. Lee HS, Park SH, Yang SK, et al. Long-term prognosis of ulcerative colitis and its temporal change between 1977 and 2013: a hospital-based cohort study from Korea. J Crohns Colitis. 2015;9:147-155.
8. Bernstein CN, Ng SC, Lakatos PL, et al. A review of mortality and surgery in ulcerative colitis: milestones of the seriousness of the disease. Inflamm Bowel Dis. 2013;19:2001-2010.
9. Edwards FC, Truelove SC. The course and prognosis of ulcerative colitis. Gut. 1963;4:299-315.
10. Jarnerot G, Rolny P, Sandberg-Gertzen H. Intensive intravenous treatment of ulcerative colitis. Gastroenterology. 1985;89:1005-1013.
11. Dinesen LC, Walsh AJ, Protic MN, et al. The pattern and outcome of acute severe colitis. J Crohns Colitis. 2010;4:431-437.
12. Gulliford SR, Limdi JK. Acute severe ulcerative colitis: timing is everything. Postgrad Med J. 2011;87:215-222.
13. Turner D, Walsh CM, Steinhart AH, et al. Response to corticosteroids in severe ulcerative colitis: a systematic review of the literature and a meta-regression. Clin Gastroenterol Hepatol. 2007;5:103-110.
14. Oshitani N, Kitano A, Fukushima R, et al. Predictive factors for the response of ulcerative colitis patients during the acute-phase treatment. Digestion. 1990;46:107-113.
15. Gulati R, Rawal KK, Kumar N, et al. Course of severe ulcerative colitis in northern India. Trop Gastroenterol. 1995;16:19-23.
16. Oshitani N, Matsumoto T, Jinno Y, et al. Prediction of short-term outcome for patients with active ulcerative colitis. Dig Dis Sci. 2000;45:982-986.
17. Seo M, Okada M, Yao T, et al. Evaluation of the clinical course of acute attacks in patients with ulcerative colitis through the use of an activity index. J Gastroenterol. 2002;37:29-34.
18. Kumar S, Ghoshal UC, Aggarwal R, et al. Severe ulcerative colitis: prospective study of parameters determining outcome. J Gastroenterol Hepatol. 2004;19:1247-1252.
19. Kim J-W, Kim HJ, Lee CK, et al. Predictors of steroid treatment failure and validation of previous models for severe attacks of ulcerative colitis [in Korean]. Intest Res. 2012;10:251-264.
20. Truelove SC, Witts LJ. Cortisone in ulcerative colitis; preliminary report on a therapeutic trial. Br Med J. 1954;2:375-378.
21. Dignass A, Eliakim R, Magro F, et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis. J Crohns Colitis. 2012;6:965-990.
22. Kornbluth A, Sachar DB. Ulcerative colitis practice guidelines in adults. American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol. 1997;92:204-211.
23. Kornbluth A, Sachar DB; Practice Parameters Committee of the American College of Gastroenterology. Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol. 2004;99:1371-1385.
24. Park SH, Yang SK, Park SK, et al. Long-term prognosis of Crohn's disease and its temporal change between 1981 and 2012: a hospital-based cohort study from Korea. Inflamm Bowel Dis. 2014;20:488-494.
25. Travis SP, Farrant JM, Ricketts C, et al. Predicting outcome in severe ulcerative colitis. Gut. 1996;38:905-910.
26. Bojic D, Radojicic Z, Nedeljkovic-Protic M, et al. Long-term outcome after admission for acute severe ulcerative colitis in Oxford: the 1992-1993 cohort. Inflamm Bowel Dis. 2009;15:823-828.
27. Kornbluth A, Sachar DB; Practice Parameters Committee of the American College of Gastroenterology. Ulcerative colitis practice guidelines in adults: American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol. 2010;105:501-523.
28. Dignass A, Lindsay JO, Sturm A, et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management. J Crohns Colitis. 2012;6:991-1030.
29. Kaplan GG, McCarthy EP, Ayanian JZ, et al. Impact of hospital volume on postoperative morbidity and mortality following a colectomy for ulcerative colitis. Gastroenterology. 2008;134:680-687.
30. de Silva S, Ma C, Proulx MC, et al. Postoperative complications and mortality following colectomy for ulcerative colitis. Clin Gastroenterol Hepatol. 2011;9:972-980.
31. Allison J, Herrinton LJ, Liu L, et al. Natural history of severe ulcerative colitis in a community-based health plan. Clin Gastroenterol Hepatol. 2008;6:999-1003.
32. Han SH, Kim H, Lee K, et al. Epidemiology and clinical features of toxigenic culture-confirmed hospital-onset Clostridium difficile infection: a multicentre prospective study in tertiary hospitals of South Korea. J Med Microbiol. 2014;63:1542-1551.
33. Kim HH, Kim YS, Han DS, et al. Clinical differences in Clostridium difficile infection based on age: a multicenter study. Scand J Infect Dis. 2014;46:46-51.
34. Kim YS, Kim YH, Kim JS, et al. The prevalence and efficacy of ganciclovir on steroid-refractory ulcerative colitis with cytomegalovirus infection: a prospective multicenter study. J Clin Gastroenterol. 2012;46:51-56.
35. Park SH, Yang SK, Hong SM, et al. Severe disease activity and cytomegalovirus colitis are predictive of a nonresponse to infliximab in patients with ulcerative colitis. Dig Dis Sci. 2013;58:3592-3599.
36. Van Assche G, Dignass A, Bokemeyer B, et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. J Crohns Colitis. 2013;7:1-33.
37. Nguyen GC, Bernstein CN, Bitton A, et al. Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease: Canadian Association of Gastroenterology. Gastroenterology. 2014;146:835-848.
38. White RH, Zhou H, Romano PS. Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California. Ann Intern Med. 1998;128:737-740.
39. Klatsky AL, Armstrong MA, Poggi J. Risk of pulmonary embolism and/or deep venous thrombosis in Asian-Americans. Am J Cardiol. 2000;85:1334-1337.